Rakesh M Suri1, Vinod H Thourani2, Brian R Englum3, J Scott Rankin4, Vinay Badhwar5, Lars G Svensson6, Gorav Ailawadi7, Michael J Mack8, Max He3, J Matthew Brennan3, Hartzell V Schaff9, James S Gammie10. 1. Department of Cardiac Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address: suri.rakesh@mayo.edu. 2. Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia. 3. Outcomes Research and Assessment Group, Duke Clinical Research Institute, Durham, North Carolina. 4. Vanderbilt University, Centennial Hospital, Nashville, Tennessee. 5. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio. 7. Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, Virginia. 8. Heart Hospital Baylor Plano, Baylor Healthcare System, Dallas, Texas. 9. Department of Cardiac Surgery, Mayo Clinic, Rochester, Minnesota. 10. Division of Cardiothoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: Although the operative risk of multivalve operations has historically been high, current outcomes are poorly understood. We sought to evaluate factors influencing contemporary results of triple-valve operations using The Society of Thoracic Surgeons Adult Cardiac Surgery Database. METHODS: Among patients undergoing combined mitral, aortic, and tricuspid valve (triple- valve) operations between 1993 and 2011, aortic valve repair patients were excluded and those having aortic valve replacement were analyzed according to whether they underwent repair vs replacement of the mitral valve (MV) and tricuspid valve (TV). Temporal trends in operative death and clinical outcomes were examined using unadjusted and adjusted analyses. RESULTS: A total of 8,021 triple-valve patients were studied. The median (25th percentile, 75th percentile) age was 67 years (59, 77 years), 4,809 (60%) were women, 4,488 (56%) had New York Heart Association class III to IV symptoms, and the mean (25th percentile, 75th percentile) ejection fraction was 50% (40%, 60%). MV repair was performed in 2,728 (34%) patients overall and increased over time from 13% (1993 to 1997) to 41% (2008 to 2011). TV repair was performed in 7,512 (94%) patients overall and increased over time from 86% (1993 to 1997) to 96% (2008 to 2011). Unadjusted operative mortality decreased from 17% in 1993 to 9% in 2011. Adjusted odds ratios (95% confidence intervals) of operative mortality were lower in those having MV repair (0.72 [0.61 to 0.85]), TV repair (0.64 [0.50 to 0.83]), and MV+TV repair (0.46 [0.34 to 0.63]) compared with those having replacements. Unadjusted and adjusted odds of stroke were similar between groups and not significant for all. CONCLUSIONS: This large series demonstrates that surgical results of triple-valve operations have continued to improve during the past 18 years. MV and TV repair were associated with improvements in early survival. Although further study is required to understand late outcomes, these data suggest that broader efforts to perform MV repair instead of replacement in this high-risk patient population appear warranted.
BACKGROUND: Although the operative risk of multivalve operations has historically been high, current outcomes are poorly understood. We sought to evaluate factors influencing contemporary results of triple-valve operations using The Society of Thoracic Surgeons Adult Cardiac Surgery Database. METHODS: Among patients undergoing combined mitral, aortic, and tricuspid valve (triple- valve) operations between 1993 and 2011, aortic valve repair patients were excluded and those having aortic valve replacement were analyzed according to whether they underwent repair vs replacement of the mitral valve (MV) and tricuspid valve (TV). Temporal trends in operative death and clinical outcomes were examined using unadjusted and adjusted analyses. RESULTS: A total of 8,021 triple-valve patients were studied. The median (25th percentile, 75th percentile) age was 67 years (59, 77 years), 4,809 (60%) were women, 4,488 (56%) had New York Heart Association class III to IV symptoms, and the mean (25th percentile, 75th percentile) ejection fraction was 50% (40%, 60%). MV repair was performed in 2,728 (34%) patients overall and increased over time from 13% (1993 to 1997) to 41% (2008 to 2011). TV repair was performed in 7,512 (94%) patients overall and increased over time from 86% (1993 to 1997) to 96% (2008 to 2011). Unadjusted operative mortality decreased from 17% in 1993 to 9% in 2011. Adjusted odds ratios (95% confidence intervals) of operative mortality were lower in those having MV repair (0.72 [0.61 to 0.85]), TV repair (0.64 [0.50 to 0.83]), and MV+TV repair (0.46 [0.34 to 0.63]) compared with those having replacements. Unadjusted and adjusted odds of stroke were similar between groups and not significant for all. CONCLUSIONS: This large series demonstrates that surgical results of triple-valve operations have continued to improve during the past 18 years. MV and TV repair were associated with improvements in early survival. Although further study is required to understand late outcomes, these data suggest that broader efforts to perform MV repair instead of replacement in this high-risk patient population appear warranted.
Authors: Steve K Singh; Gilbert H L Tang; Manjula D Maganti; Susan Armstrong; William G Williams; Tirone E David; Michael A Borger Journal: Ann Thorac Surg Date: 2006-11 Impact factor: 4.330
Authors: Robert J Moraca; Marc R Moon; Jennifer S Lawton; Tracey J Guthrie; Kristen A Aubuchon; Nader Moazami; Michael K Pasque; Ralph J Damiano Journal: Ann Thorac Surg Date: 2009-01 Impact factor: 4.330
Authors: Subhasis Chatterjee; J Scott Rankin; James S Gammie; Shubin Sheng; Sean M O'Brien; J Matthew Brennan; John C Alexander; Vinod H Thourani; Paul J Pearson; Rakesh M Suri Journal: Ann Thorac Surg Date: 2013-09-05 Impact factor: 4.330
Authors: Rakesh M Suri; Hartzell V Schaff; Joseph A Dearani; Thoralf M Sundt; Richard C Daly; Charles J Mullany; Maurice Enriquez-Sarano; Thomas A Orszulak Journal: Ann Thorac Surg Date: 2006-09 Impact factor: 4.330
Authors: Vinod H Thourani; William S Weintraub; Robert A Guyton; Ellis L Jones; Willis H Williams; Sharif Elkabbani; Joseph M Craver Journal: Circulation Date: 2003-06-30 Impact factor: 29.690
Authors: A Marc Gillinov; Eugene H Blackstone; Edward R Nowicki; Worawong Slisatkorn; Ghannam Al-Dossari; Douglas R Johnston; Kristopher M George; Penny L Houghtaling; Brian Griffin; Joseph F Sabik; Lars G Svensson Journal: J Thorac Cardiovasc Surg Date: 2008-03-04 Impact factor: 5.209